RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26327203http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26327203http://www.w3.org/2000/01/rdf-schema#comment"The metalloproteinase SAS1B [ovastacin, ASTL, astacin-like] was immunolocalized on the oolemma of ovulated human oocytes and in normal ovaries within the pool of growing oocytes where SAS1B protein was restricted to follicular stages spanning the primary-secondary follicle transition through ovulation. Gene-specific PCR and immunohistochemical studies revealed ASTL messages and SAS1B protein in both endometrioid [74%] and malignant mixed Mullerian tumors (MMMT) [87%] of the uterus. A MMMT-derived cell line, SNU539, expressed cell surface SAS1B that, after binding polyclonal antibodies, internalized into EEA1/LAMP1-positive early and late endosomes. Treatment of SNU539 cells with anti-SAS1B polyclonal antibodies caused growth arrest in the presence of active complement. A saporin-immunotoxin directed to SAS1B induced growth arrest and cell death. The oocyte restricted expression pattern of SAS1B among adult organs, cell-surface accessibility, internalization into the endocytic pathway, and tumor cell growth arrest induced by antibody-toxin conjugates suggest therapeutic approaches that would selectively target tumors while limiting adverse drug effects in healthy cells. The SAS1B metalloproteinase is proposed as a prototype cancer-oocyte tumor surface neoantigen for development of targeted immunotherapeutics with limited on-target/off tumor effects predicted to be restricted to the population of growing oocytes."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.org/dc/terms/identifier"doi:10.18632/oncotarget.4734"xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Li H."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Thomas T."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Herr J.C."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Mandal A."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"D'Souza R.S."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Flickinger C.J."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Pollok B.A."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Jazaeri A.A."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Gougeon A."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Stoler M.H."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Bruns D.E."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Pires E.S."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Herr A.K."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Anderson-Knapp K.L."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/author"Needham M.A."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/name"Oncotarget"xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/pages"30194-30211"xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/title"Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors."xsd:string
http://purl.uniprot.org/citations/26327203http://purl.uniprot.org/core/volume"6"xsd:string
http://purl.uniprot.org/citations/26327203http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26327203
http://purl.uniprot.org/citations/26327203http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26327203